Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin Ezekowitz

Showing results (61-70 of 109) with videos related to

Pageof 11
Sort By:
European Journal of Heart Failure|January 29, 2016
Nesiritide in patients hospitalized for acute heart failure: does timing matter? Implication for future acute heart failure trialsYee Weng Wong, Robert J Mentz, G Michael Felker, et al.
European Heart Journal|April 19, 2013
Outcomes of apixaban vs. warfarin by type and duration of atrial fibrillation: results from the ARISTOTLE trialSana M Al-Khatib, Laine Thomas, Lars Wallentin, et al.
European Journal of Heart Failure|September 1, 2023
Relationship between baseline electrocardiographic measurements and outcomes in patients with high-risk heart failure: Insights from the VerICiguaT Global Study in Subjects with Heart Failure with Reduced Ejection Fraction (VICTORIA) trialHaran Yogasundaram, Yinggan Zheng, Eric Ly, et al.
Journal of Cardiac Failure|January 12, 2023
Circulating Angiokines Are Associated With Reverse Remodeling and Outcomes in Chronic Heart FailureJosephine Harrington, Andrew B Nixon, Melissa A Daubert, et al.
The Canadian Journal of Cardiology|May 11, 2023
Canadian Cardiovascular Society-Canadian Heart Failure Society Focused Clinical Practice Update of Patients With Differing Heart Failure PhenotypesAnique Ducharme, Shelley Zieroth, Vineeta Ahooja, et al.
Circulation. Heart Failure|August 19, 2021
Participation in a Heart Failure Clinical Trial: Perspectives and Opportunities From the VICTORIA Trial and VICTORIA Simultaneous RegistryJustin Ezekowitz, Robert J Mentz, Cynthia M Westerhout, et al.
Journal of the American College of Cardiology|September 2, 2025
Pharmacological Treatment of Heart Failure with Reduced Ejection Fraction: An Updated Systematic Review and Network Meta-AnalysisBart J van Essen, Daan C H Ceelen, Wouter Ouwerkerk, et al.
JACC. Heart Failure|January 23, 2026
Standardized Reporting in Heart Failure Noninvasive Remote Monitoring Trials: Interventions to Catalyze Data Into ActionElise L Shalowitz, Pardeep Jhund, Mitchell A Psotka, et al.
European Journal of Heart Failure|March 7, 2024
Diuretic use and outcomes in patients with heart failure with reduced ejection fraction: Insights from the VICTORIA trialJustin Ezekowitz, Wendimagegn Alemayehu, Frank Edelmann, et al.
Journal of the American Heart Association|November 8, 2021
Blood Pressure and Safety Events With Vericiguat in the VICTORIA TrialCarolyn S P Lam, Hillary Mulder, Yuri Lopatin, et al.
Pageof 11

Showing results (61-70 of 109) with videos related to

Sort By:
Pageof 11
European Journal of Heart Failure|January 29, 2016
Nesiritide in patients hospitalized for acute heart failure: does timing matter? Implication for future acute heart failure trialsYee Weng Wong, Robert J Mentz, G Michael Felker, et al.
European Heart Journal|April 19, 2013
Outcomes of apixaban vs. warfarin by type and duration of atrial fibrillation: results from the ARISTOTLE trialSana M Al-Khatib, Laine Thomas, Lars Wallentin, et al.
European Journal of Heart Failure|September 1, 2023
Relationship between baseline electrocardiographic measurements and outcomes in patients with high-risk heart failure: Insights from the VerICiguaT Global Study in Subjects with Heart Failure with Reduced Ejection Fraction (VICTORIA) trialHaran Yogasundaram, Yinggan Zheng, Eric Ly, et al.
Journal of Cardiac Failure|January 12, 2023
Circulating Angiokines Are Associated With Reverse Remodeling and Outcomes in Chronic Heart FailureJosephine Harrington, Andrew B Nixon, Melissa A Daubert, et al.
The Canadian Journal of Cardiology|May 11, 2023
Canadian Cardiovascular Society-Canadian Heart Failure Society Focused Clinical Practice Update of Patients With Differing Heart Failure PhenotypesAnique Ducharme, Shelley Zieroth, Vineeta Ahooja, et al.
Circulation. Heart Failure|August 19, 2021
Participation in a Heart Failure Clinical Trial: Perspectives and Opportunities From the VICTORIA Trial and VICTORIA Simultaneous RegistryJustin Ezekowitz, Robert J Mentz, Cynthia M Westerhout, et al.
Journal of the American College of Cardiology|September 2, 2025
Pharmacological Treatment of Heart Failure with Reduced Ejection Fraction: An Updated Systematic Review and Network Meta-AnalysisBart J van Essen, Daan C H Ceelen, Wouter Ouwerkerk, et al.
JACC. Heart Failure|January 23, 2026
Standardized Reporting in Heart Failure Noninvasive Remote Monitoring Trials: Interventions to Catalyze Data Into ActionElise L Shalowitz, Pardeep Jhund, Mitchell A Psotka, et al.
European Journal of Heart Failure|March 7, 2024
Diuretic use and outcomes in patients with heart failure with reduced ejection fraction: Insights from the VICTORIA trialJustin Ezekowitz, Wendimagegn Alemayehu, Frank Edelmann, et al.
Journal of the American Heart Association|November 8, 2021
Blood Pressure and Safety Events With Vericiguat in the VICTORIA TrialCarolyn S P Lam, Hillary Mulder, Yuri Lopatin, et al.
Pageof 11